These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 28993329)

  • 1. Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative Pathogens.
    Ito R; Tomich AD; McElheny CL; Mettus RT; Sluis-Cremer N; Doi Y
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and Dynamics of FosA-Mediated Fosfomycin Resistance in Klebsiella pneumoniae and Escherichia coli.
    Klontz EH; Tomich AD; Günther S; Lemkul JA; Deredge D; Silverstein Z; Shaw JF; McElheny C; Doi Y; Wintrode PL; MacKerell AD; Sluis-Cremer N; Sundberg EJ
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli.
    Guo Q; Tomich AD; McElheny CL; Cooper VS; Stoesser N; Wang M; Sluis-Cremer N; Doi Y
    J Antimicrob Chemother; 2016 Sep; 71(9):2460-5. PubMed ID: 27261267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-Molecule Inhibitor of FosA Expands Fosfomycin Activity to Multidrug-Resistant Gram-Negative Pathogens.
    Tomich AD; Klontz EH; Deredge D; Barnard JP; McElheny CL; Eshbach ML; Weisz OA; Wintrode P; Doi Y; Sundberg EJ; Sluis-Cremer N
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of fosfomycin resistance and plasmid-mediated fosfomycin-modifying enzymes among carbapenem-resistant Enterobacteriaceae in Zhejiang, China.
    Huang L; Hu YY; Zhang R
    J Med Microbiol; 2017 Sep; 66(9):1332-1334. PubMed ID: 28885139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal
    Ito R; Mustapha MM; Tomich AD; Callaghan JD; McElheny CL; Mettus RT; Shanks RMQ; Sluis-Cremer N; Doi Y
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay among Different Fosfomycin Resistance Mechanisms in Klebsiella pneumoniae.
    Ortiz-Padilla M; Portillo-Calderón I; de Gregorio-Iaria B; Blázquez J; Rodríguez-Baño J; Pascual A; Rodríguez-Martínez JM; Docobo-Pérez F
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of Fosfomycin Resistance Determinant
    Chen L; Ou B; Zhang M; Chou CH; Chang SK; Zhu G
    Microb Drug Resist; 2021 Mar; 27(3):415-423. PubMed ID: 32667841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of
    Elliott ZS; Barry KE; Cox HL; Stoesser N; Carroll J; Vegesana K; Kotay S; Sheppard AE; Wailan A; Crook DW; Parikh H; Mathers AJ
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31340992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of Plasmid-Mediated Fosfomycin-Resistance Genes among Escherichia coli Isolates, France.
    Benzerara Y; Gallah S; Hommeril B; Genel N; Decré D; Rottman M; Arlet G
    Emerg Infect Dis; 2017 Sep; 23(9):1564-1567. PubMed ID: 28820368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical agar-based disk potentiation test for detection of fosfomycin-nonsusceptible Escherichia coli clinical isolates producing glutathione S-transferases.
    Nakamura G; Wachino J; Sato N; Kimura K; Yamada K; Jin W; Shibayama K; Yagi T; Kawamura K; Arakawa Y
    J Clin Microbiol; 2014 Sep; 52(9):3175-9. PubMed ID: 24951800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphonoformate: a minimal transition state analogue inhibitor of the fosfomycin resistance protein, FosA.
    Rigsby RE; Rife CL; Fillgrove KL; Newcomer ME; Armstrong RN
    Biochemistry; 2004 Nov; 43(43):13666-73. PubMed ID: 15504029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A promising target for treatment of multidrug-resistant bacterial infections.
    Davey MS; Tyrrell JM; Howe RA; Walsh TR; Moser B; Toleman MA; Eberl M
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3635-6. PubMed ID: 21537011
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.
    Lee SY; Park YJ; Yu JK; Jung S; Kim Y; Jeong SH; Arakawa Y
    J Antimicrob Chemother; 2012 Dec; 67(12):2843-7. PubMed ID: 22893681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy.
    Sime FB; Johnson A; Whalley S; Santoyo-Castelazo A; Montgomery AB; Walters KA; Lipman J; Hope WW; Roberts JA
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of fosA5, a new plasmid-mediated fosfomycin resistance gene in Escherichia coli.
    Ma Y; Xu X; Guo Q; Wang P; Wang W; Wang M
    Lett Appl Microbiol; 2015 Mar; 60(3):259-64. PubMed ID: 25441705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The target of daptomycin is absent from Escherichia coli and other gram-negative pathogens.
    Randall CP; Mariner KR; Chopra I; O'Neill AJ
    Antimicrob Agents Chemother; 2013 Jan; 57(1):637-9. PubMed ID: 23114759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Detection of
    Nigiz Ş; Hazırolan G; Köseoglu Eser Ö; Gür D
    Microb Drug Resist; 2022 Mar; 28(3):317-321. PubMed ID: 34851744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Hickman RA; Hughes D; Cars T; Malmberg C; Cars O
    Clin Microbiol Infect; 2014 Apr; 20(4):O267-73. PubMed ID: 24118201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and mechanisms of fosfomycin resistance among KPC-producing Klebsiella pneumoniae clinical isolates in China.
    Huang L; Cao M; Hu Y; Zhang R; Xiao Y; Chen G
    Int J Antimicrob Agents; 2021 Jan; 57(1):106226. PubMed ID: 33212165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.